Prof. Jacob See-Tong Pang (Feng) graduated from Chung-Shan Medical College, Taiwan. Upon completion of his medical and surgical residency training and driven by his strong interest in 1990 in medical research, he pursued his advanced study at the Karolinska Institute, Sweden and obtained his PhD degree on 2003. He was the chief of the Department of Uro-Oncology at Chang Gung Memorial Hospital from 2007 to 2014 and was the director of the Chang Gung Robotic Surgery Center. Ever since he completed the first robotic surgery at Chang Gung Memorial Hospital in September, 2006, he has completed more than 650 robotic surgeries including prostatectomy, partial nephrectomy, cystectomy nephroureterectomy and etc. He is promoted to the vice-superintendent of the Chang Gung Memorial Hospital, LinKou in july 2017. Prof. Pang actively involves in both clinical and translation research. His research effort focuses on understanding and improving clinical outcomes of patients with urological cancer. Of note, he co-led the research team to elucidate the mutational signature of aristolochic acid-associated upper urinary tract urothelial cell carcinoma (UTUC) and published the results in Science Translational Medicine. Thus far, he has published numerous peer-reviewed articles in many renowned medical journals.
Linkou Chang Gung Memorial Hospital
Taoyuan City, Taiwan
Division of Urology, Department of Surgery
2018 American Association for Cancer Research (AACR) Team Science Award
American Association for Cancer Research (AACR)
2018: Genomic Approaches to Preventing and Treating Asian-Prevalent Cancers Team For leveraging a diverse suite of complementary genomic technologies to illuminate underlying causes and key disrupted molecular pathways in Asian-prevalent cancers, with the aim of enhancing prevention and treatment.